FI972763A0 - Mutantproteiner - Google Patents

Mutantproteiner

Info

Publication number
FI972763A0
FI972763A0 FI972763A FI972763A FI972763A0 FI 972763 A0 FI972763 A0 FI 972763A0 FI 972763 A FI972763 A FI 972763A FI 972763 A FI972763 A FI 972763A FI 972763 A0 FI972763 A0 FI 972763A0
Authority
FI
Finland
Prior art keywords
mutant proteins
mutant
proteins
Prior art date
Application number
FI972763A
Other languages
English (en)
Finnish (fi)
Other versions
FI972763A (sv
Inventor
Joachim Hauber
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI972763A0 publication Critical patent/FI972763A0/sv
Publication of FI972763A publication Critical patent/FI972763A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI972763A 1995-02-13 1997-06-26 Mutantproteiner FI972763A (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds
PCT/EP1996/000585 WO1996025492A1 (en) 1995-02-13 1996-02-12 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS

Publications (2)

Publication Number Publication Date
FI972763A0 true FI972763A0 (sv) 1997-06-26
FI972763A FI972763A (sv) 1997-10-10

Family

ID=26306494

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972763A FI972763A (sv) 1995-02-13 1997-06-26 Mutantproteiner

Country Status (15)

Country Link
EP (1) EP0811060A1 (sv)
JP (1) JPH10509327A (sv)
KR (1) KR19980702160A (sv)
CN (1) CN1173897A (sv)
AU (1) AU4665196A (sv)
BR (1) BR9606951A (sv)
CA (1) CA2210538A1 (sv)
CZ (1) CZ255397A3 (sv)
FI (1) FI972763A (sv)
HU (1) HUP9801681A3 (sv)
IL (1) IL117113A0 (sv)
NO (1) NO973679L (sv)
PL (1) PL321239A1 (sv)
SK (1) SK109997A3 (sv)
WO (1) WO1996025492A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448040B1 (en) * 1997-06-20 2002-09-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibitor of cellular proliferation
US7381708B2 (en) 2001-07-23 2008-06-03 Sensco Technologies, Inc. Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
US7968523B2 (en) 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US6867237B1 (en) * 2001-07-23 2005-03-15 Senesco Technologies, Inc. DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
NZ542665A (en) 2003-03-05 2008-05-30 Senesco Technologies Inc Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
WO2005007853A2 (en) * 2003-06-06 2005-01-27 Senesco Technologies, Inc. Inhibition of apoptosis-specific elf-5a (“eif-5a1”) with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics
CN102282259A (zh) 2008-03-07 2011-12-14 森尼斯科技术公司 与有义构建体实现期望多核苷酸的表达的用途相组合的、sirna实现内源基因的减量调节的用途
US8445638B2 (en) 2008-09-03 2013-05-21 Senesco Technologies, Inc. Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Also Published As

Publication number Publication date
EP0811060A1 (en) 1997-12-10
BR9606951A (pt) 1997-10-28
KR19980702160A (ko) 1998-07-15
HUP9801681A3 (en) 2000-10-30
SK109997A3 (en) 1998-04-08
MX9705757A (es) 1998-07-31
CZ255397A3 (cs) 1998-02-18
AU4665196A (en) 1996-09-04
JPH10509327A (ja) 1998-09-14
IL117113A0 (en) 1996-06-18
CA2210538A1 (en) 1996-08-22
CN1173897A (zh) 1998-02-18
HUP9801681A2 (hu) 1998-10-28
WO1996025492A1 (en) 1996-08-22
FI972763A (sv) 1997-10-10
NO973679L (no) 1997-10-13
PL321239A1 (en) 1997-11-24
NO973679D0 (no) 1997-08-11

Similar Documents

Publication Publication Date Title
FI973223A0 (fi) Behaollararrangemang med klaofingringsavsloejande sigill
ATA135896A (de) Skibob
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
BR9609671A (pt) Amino uracilas substituídas
FI972763A (sv) Mutantproteiner
FI2165U1 (fi) Skyddande trosor med aoteranvaendbar sugdel
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
FI974362A0 (fi) SMAW-svetsning med kontinuerlig hoegfrekvens
DE59600405D1 (de) Gehhilfe
FI101773B (sv) Hjälpmedel
FI2052U1 (fi) Med skaft foersett skodon
FI2178U1 (fi) Baeddsoffa/faotoelj med laoda foer saengklaeder
FI1936U1 (fi) Skaerplaoda med raklam
FI2223U1 (fi) Vaexellastare med vikbom
FI954042A0 (fi) Kabelvinsch med drag- och skjutfunktion
FI954826A0 (fi) Handdriven varukaerra med utjaemningsanordning
FI953714A0 (fi) Avfallskomppostor med tvaestomme
FI953347A0 (fi) Med vindkraft fungerande vattenkraftstation
FI955170A0 (fi) Stoedbaoge med laekemedelsdynor
FI951905A0 (fi) Egendomsmaerkningssystem med fjaerravlaesningsteknik
FI950901A0 (fi) Vaoningshus med traekonstruktion
FI952224A0 (fi) Glasfiberarbetens foerstaenkande med traefibermattor
FIU950024U0 (fi) Icjakt med svaengbara skidor